Apr 16 |
Connect Biopharma GAAP EPS of -$2.15 misses by $1.33
|
Apr 16 |
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
|
Mar 19 |
Connect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual Conference
|
Feb 12 |
Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
|
Jan 29 |
Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?
|
Dec 18 |
Are Medical Stocks Lagging Bausch Health (BHC) This Year?
|
Dec 12 |
Connect Biopharma gains as asthma candidate succeeds in mid-stage trial
|
Dec 12 |
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
|
Dec 11 |
Connect Biopharma to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12, 2023
|
Nov 30 |
Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management
|